Abstract
Osteoporosis is a common complication of chronic liver disease, from cholestatic disorders to autoimmune, alcoholic, and posthepatitic cirrhosis. Osteoporosis appears more striking in patients with primary biliary cirrhosis (PBC) because the disease usually affects elderly women, who are naturally prone to osteoporosis. Our aims were (1) to compare the prevalence of osteoporosis (T-score ≤2.5 SD) between PBC patients and a group of age-and sex-matched controls consisting of healthy subjects from the general population; and (2) to identify the main risk factors for the development of bone loss. Thirty-three women with PBC (mean age, 47.3 ± 10.4 years) and 66 healthy subjects were enrolled in the study. Bone mineral density (BMD) was assessed at the lumbar spine by dual-photon X-ray absorptiometry. Bone metabolism was evaluated by measuring serum calcium corrected for serum albumin, 25-hydroxyvitamin D (25-OH vit D), parathyroid hormone, and osteocalcin. Vertebral fractures were analyzed using vertebral fracture assessment (VFA). The mean T-score was lower in the PBC group compared to healthy controls, with a significant statistical difference (−2.39 ± 0.93 and −1.47 ± 0.99 in lumbar spine and total hip, respectively, in the PBC group versus −0.99 ± 0.51 and −0.56 ± 1.14 in healthy controls (P < 0.001). The prevalence of osteoporosis was 51.5% in the PBC group versus 22.7% in healthy controls with a statistically significant difference (P = 0.004). BMD of the PBC group was significantly correlated positively with body mass index (BMI) and 25-OH vit D, and negatively with menopausal status, duration of disease, and parathyroid hormone (PTH) levels. Vertebral fractures were present in 9% of the patients. We found that osteoporosis is more prevalent in women with PBC than in the general population. BMI, menopausal status, duration of the disease, and vitamin D deficiency are the main risk factors for osteoporosis in this liver disease.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Eastell R, Dickson ER, Hodgson SF, Wiesner RH, Porayko MK, Wahner HW, Cedel SL, Riggs BL, Krom RA (1991) Rates of vertebral bone loss before and after liver transplantation in patients with primary biliary cirrhosis. Hepatology 14:296–300
Lindor KD (1993) Management of osteopenia of liver disease with special emphasis on primary biliary cirrhosis. Semin Liver Dis 13:367–373
Hay JE (1995) Bone disease in cholestatic liver disease. Gastroenterology 108:276–283
Guañabens N, Parés A, Mariñoso L, Brancós MA, Piera C, Serrano S, Rivera F, Rodés J (1990) Factors influencing the development of metabolic bone disease in primary biliary cirrhosis. Am J Gastroenterol 85:1356–1362
Solerio E, Isaia G, Innarella R, Di Stefano M, Farina M, Borghesio E, Framarin L, Rizzetto M, Rosina F (2003) Osteoporosis: still a typical complication of primary biliary cirrhosis? Dig Liver Dis 35:339–346
AGA Technical Review on Osteoporosis in Hepatic Disorders (2003) Gastroenterology 125:941–966
Hodgson SF, Dickson ER, Eastell R, Eriksen EF, Bryant SC, Riggs BL (1993) Rates of cancellous bone remodelling and turnover in osteopenia associated with primary biliary cirrhosis. Bone (NY) 14:819–827
Hodgson SF, Dickson ER, Wahner HW, Johnson KA, Mann KG, Riggs BL (1985) Bone loss and reduced osteoblast function in primary biliary cirrhosis. Ann Intern Med 103:855–860
Janes CH, Dickson ER, Okazaki R, Bonde S, McDonagh AF, Riggs BL (1995) Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice. J Clin Invest 95:2581–2586
Parés A, Guañabens N, Alvarez L, De Osaba MJ, Oriola J, Pons F, Caballería L, Monegal A, Salvador G, Jo J, Peris P, Rivera F, Ballesta AM, Rodés J (2001) Collagen type I a1 and vitamin D receptor gene polymorphisms and bone mass in primary biliary cirrhosis. Hepatology 33:554–560
Springer JE, Cole DE, Rubin LA, Cauch-Dudek K, Harewood L, Evrovski J, Peltekova VD, Heathcote EJ (2000) Vitamin Dreceptor genotypes as independent genetic predictors of decreased bone mineral density in primary biliary cirrhosis. Gastroenterology 118:145–151
El Maghraoui A, Do Santos Zounon AA, Jroundi I, Nouijai A, Ghazi M, Achemlal L, Bezza A, Tazi MA, Abouqual R (2005) Reproducibility of bone mineral density measurements using dual X-ray absorptiometry in daily clinical practice. Osteoporos Int 16(12):1742–1748
El Maghraoui A, Achemlal L, Bezza A (2006) Monitoring of dual energy x-ray absorptiometry measurement in clinical practice. J Clin Densitom 9(3):281–286
El Maghraoui A, Guerboub AA, Mounach A, Ghozlani I, Nouijai A, Ghazi M, Achemlal L, Bezza A, Tazi MA (2007) Body mass index and gynecological factors as determinants of bone mass in healthy Moroccan postmenopausal women. Maturitas 56(4): 375–382
El Maghraoui A, Guerboub AA, Achemlal L, Mounach A, Nouijai A, Ghazi M, Bezza A, Tazi MA (2006) Bone mineral density of the spine and femur in healthy Moroccan women. J Clin Densitom 9(4):454–460
Ludwig J, Dickson ER, McDonald GSA (1978) Staging of chronic non-suppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anat Histol 379:103–110
Hay JE, Lindor KD, Wiesner RH (1991) The metabolic bone disease of primary sclerosing cholangitis. Hepatology 14:257–261
Lindor KD, Janes CH, Crippin JS, Jorgensen RA, Dickson ER (1995) Bone disease in primary biliary cirrhosis: does ursodeoxycholic acid make a difference? Hepatology 21:389–392
Diamond TH, Stiel D, Lunzer M, McDowall D, Eckstein RP, Posen S (1989) Hepatic osteodystrophy static and dynamic bone histomorphometry and bone Gla-protein in 80 patients with chronic liver disease. Gastroenterology 96:213–221
Diamond-Hodgson SF, Dickson ER, Wahner HW, Johnson KA, Mann KG, Riggs BL (1985) Bone loss and reduced osteoblast function in primary biliary cirrhosis. Ann Intern Med 103:855–860
Trautwein C, Possienke P, Schlitt H, Klaus H, Roland H, Rudolph R, et al. (2000) Bone density and metabolism in patients with viral hepatitis and cholestatic liver diseases before and after liver transplantation. Am J Gastroenterol 95:2343–2351
Rosen H (1996) Primary biliary cirrhosis and bone disease. Hepatology 21:253–255
Crosbie OM, Freaney R, McKenna MJ, Hegarty JE (1999) Bone density, Vitamin D status, and disordered bone remodeling in endstage chronic liver disease. Calcif Tissue Int 64:295–300
Guichelaar M, Hay J, Egan K, Therneau T (2000) Incidence and pretransplant risk factors for posttransplant fractures in patients with chronic cholestatic liver disease. J Hepatol 32:49
Menon K, Angulo P, Weston S, Dickson E, Lindor K (2001) Bone disease in primary biliary cirrhosis: independent indicators and rate of progression. J Hepatol 35:316–323
Pares A, Guanabens N, Ros I, Caballeria L, Pons F, Vidal S, Monegal A, Peris P, Rodes J (2002) Duration and severity of the disease but not menopausal status are the main risk factors for osteoporosis in primary biliary cirrhosis. J Hepatol 36:154–155
Mitchison HC, Malcolm AJ, Bassendine MF, James OF (1988) Metabolic bone disease in primary biliary cirrhosis at presentation. Gastroenterology 94:463–470
Cuthbert JA, Pak CY, Zerwekh JE, Glass KD, Combes B (1984) Bone disease in primary biliary cirrhosis: increased bone resorption and turnover in the absence of osteoporosis or osteomalacia. Hepatology 4(1–8):1091–1095
Bagur A, Mautalen C, Findor J, Sorda J, Somoza J (1998) Risk factors for the development of vertebral and total skeleton osteoporosis in patients with primary biliary cirrhosis. Calcif Tissue Int 63:385–390
Allali F, El Aichaoui S, Benyahya B, Khazani H, Saoud B, Abouqal R, Hajjaj-Hassouni H (2006) Hypovitaminosis D in a sunny country: relation to lifestyle, bone markers and bone mineral density. Ann Rheum Dis 65(suppl 2):412
Pereira SP, Bray GP, Pitt PI, Li FM, Moniz C, Williams R (1999) Noninvasive assessment of bone density in primary biliary cirrhosis. Eur J Gastroenterol Hepatol 11:323–328
Shih MS, Anderson C (1987) Does “hepatic osteodystrophy” differ from peri-and postmenopausal osteoporosis? A histomorphometric study. Calcif Tissue Int 41:187–191
Hay JE, Lindor KD, Wiesner RH, Dickson ER, Krom RA, LaRusso NF (1991) The metabolic bone disease of primary sclerosing cholangitis. Hepatology 14:257–261
Floreani A, Fries W, Luisetto G, Burra P, Fagiuoli S, Boccagni P, Della Rovere GR, Plebani M, Piccoli A, Naccarato R (1998) Bone metabolism in orthotopic liver transplantation: a prospective study. Liver Transpl Surg 4:311–319
Ormarsdottir S, Ljunggren O, Mallmin H, Brahm H, Loof L (1999) Low body mass index and use of corticosteroids, but not cholestasis, are risk factors for osteoporosis in patients with chronic liver disease. J Hepatol 31:84–90
Linderthal B, Leuschner MS, Ackerman H, Happ J, Leuschner UF (2000) Is primary biliary cirrhosis (PBC) in itself a risk factor for osteoporosis? Hepatology 32:168A
Floreani A, Mega A, Camozzi V, Baldo V, Plebani M, Burra P, Luisetto G (2005) Is osteoporosis a peculiar association with primary biliary cirrhosis? World J Gastroenterol 11(34):5347–5350
Le Gars L, Grandpierre C, Chazouilleres O, Berenbaum F, Poupon R (2002) Bone loss in primary biliary cirrhhosis: absence of association with severity of liver disease. Joint Bone Spine 69:195–200
Olsson R, Johansson C, Lindstedt G, Mellstrom D (1994) Risk factors for bone loss in chronic active hepatitis and primary biliary cirrhosis. Scand J Gastroenterol 29:753–756
Diamond T, Stiel D, Lunzer M, Wilkinson M, Roche J, Posen S (1990) Osteoporosis and skeletal fractures in chronic liver disease. Gut 31:82–87
Guanabens N, Pares A, Navasa M, Martinez de Osaba MJ, Hernandez ME, Munoz J, Rodes J (1994) Cyclosporin A increases the biochemical markers of bone remodeling in primary biliary cirrhosis. J Hepatol 21:24–28
Lindor KD, Jorgensen RA, Tiegs RD, Khosla S, Dickson ER (2000) Etidronate for osteoporosis in primary biliary cirrhosis: a randomized trial. J Hepatol 33:878–882
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Mounach, A., Ouzzif, Z., Wariaghli, G. et al. Primary biliary cirrhosis and osteoporosis: a case-control study. J Bone Miner Metab 26, 379–384 (2008). https://doi.org/10.1007/s00774-007-0833-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00774-007-0833-1